Episode

e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study

Podcast
The Evidence Based Rheumatology Podcast
Published
Jun 12, 2025
Duration seconds
858
Processing state
not_requested
Canonical source
https://msputman.podbean.com/e/e124-mtx-vs-pred-for-pulmonary-sarcoidosis-predmeth-study/
Audio
https://mcdn.podbean.com/mf/web/cjkadqcwihiikn5q/e124.mp3
JSON
/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e124-mtx-vs-pred-for-pulmonary-sarcoidosis-predmeth-study
Markdown
/podcast/the-evidence-based-rheumatology-podcast-1130175/e124-mtx-vs-pred-for-pulmonary-sarcoidosis-predmeth-study.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e124-mtx-vs-pred-for-pulmonary-sarcoidosis-predmeth-study/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e124-mtx-vs-pred-for-pulmonary-sarcoidosis-predmeth-study.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Interesting NEJM trial this week comparing methotrexate to prednisone for pulmonary sarcoidosis. Paper available here: https://www.nejm.org/doi/full/10.1056/NEJMoa2501443